Clinical Trials Update: May 22, 2006
Epilepsy Allergies & Asthma Pregnancy
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
NeuroPace, Inc is sponsoring an investigational study of the Responsive Neurostimulator system, the company's responsive brain stimulation therapy for refractory epilepsy. Study participation is expected to last two to three years. All participants in the trial will be implanted with the RNS device. Volunteers 18-70 with disabling motor simple partial seizures, complex partial seizures, and/or secondarily generalized seizures who have failed treatment with a minimum of two anti-seizure medications may qualify.
The research site is in Augusta, Ga.
Allergies & Asthma
Volunteers 15 and older with seasonal allergies and asthma treated with daily controller medications are needed for a research study. Candidates who have had persistent asthma for at least three months, have had symptoms for two allergy seasons, and have been on stable medications for four weeks may be eligible.
The research site is in Sylvania, Ohio.
This clinical trial will evaluate continuation rates, side effects and acceptability of NuvaRing versus OrthoEvra. Healthy women who are having periods and are currently using birth control pills or have stopped using birth control pills within the last three months may qualify. Candidates cannot have had a stroke or heart disease, hypertension, or received an investigative drug within the past two months.
The research site is in Norfolk, Va.
Copyright 2006 CenterWatch. All rights reserved.